AI analysis of bioinfo from patient blood and tissue at the Point of Care
IR-MED’s platform is based on the use of harmless infrared detection technology to collect bioinformation from a patient’s blood and tissue in a safe and noninvasive manner, without drawing blood. The gathered bioinfo undergoes classification and analysis in our AI system, providing real-time clinical decision support. Results of the analysis are delivered to healthcare providers and a patient’s electronic medical record.
Infrared Spectroscopy
Enabling products to see beneath the skin
Our infrared technology gathers information from biomarkers in different layers of the skin through optical scanning as follows:
- Biomarker profiles are identified for a given medical condition.
- A handheld device that contains miniaturized electronics and passive sensors is placed on the skin, where it emits and detects visible light and infrared light.
- Biological information is acquired by evaluating light intensity and patterns reflected from the different layers beneath the skin’s surface.
AI-powered decision support
Answering clinical questions at the Point of Care
The AI system compares bioinformation acquired by the device to a condition-specific biomarker profile to determine whether a certain area is healthy or diseased The underlying enabler for this is the fact that healthy and diseased tissue absorb and reflect light differently.
